FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

703673007: Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action (substance)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3009365018 Sodium glucose cotransporter subtype 2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3520826018 Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3559322015 Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

11 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium glucose cotransporter subtype 2 inhibitor Is a agent antidiabétique false Inferred relationship Some
Sodium glucose cotransporter subtype 2 inhibitor Is a Enzyme inhibitor false Inferred relationship Some
Sodium glucose cotransporter subtype 2 inhibitor Is a A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. false Inferred relationship Some
Sodium glucose cotransporter subtype 2 inhibitor This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Sodium glucose cotransporter subtype 2 inhibitor (disposition) true Inferred relationship Some
Sodium glucose cotransporter subtype 2 inhibitor Is a Substance categorized by disposition false Inferred relationship Some
Sodium glucose cotransporter subtype 2 inhibitor Is a Substance with cellular transport inhibitor mechanism of action (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Dapagliflozin (substance) Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Canagliflozin Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Empagliflozin Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Product containing sodium glucose cotransporter subtype 2 inhibitor (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some 1
Ertugliflozin Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Dapagliflozin propanediol Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Canagliflozin hemihydrate (substance) Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Dapagliflozin propanediol monohydrate (substance) Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Ertugliflozin pidolate Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Remogliflozin etabonate Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Canagliflozin anhydrous Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some
Dapagliflozin propanediol anhydrous Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Some

This concept is not in any reference sets

Back to Start